Clinical Trials Logo

Clinical Trial Summary

The purpose of this study was to use participant samples to simultaneously evaluate three nucleic acid amplification tests (NAATs) diagnostic platforms.


Clinical Trial Description

Background & Significance: Infections due to Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT) are major threats to public health. Most CT and NG infections are asymptomatic, but infection can lead to serious sequelae, including infertility, chronic pelvic pain, adverse obstetrical outcomes, increased risk of acquiring the human immunodeficiency virus (HIV), and disseminated infection.

There has also been growing concern over antibiotic resistance. In 2013, the US Centers for Disease Control and Prevention (CDC) classified drug-resistant NG as one of the three urgent-level resistant bacteria. Improved detection of extragenital NG is thought to be a crucial component of adequate treatment and for prevention of further resistance.

Currently, the CDC recommends using NAATs to screen and diagnose for NG and CT in the genitourinary tract due to their superior sensitivity compared to traditional culture methods. There are currently no FDA-approved commercial NAAT tests for the detection of pharyngeal and rectal NG or CT infections. The goal of this study is to evaluate the diagnostic performance of three NAAT assays for detection of extragenital NG and CT infections.

Design & Procedures: A cross-sectional, single visit study evaluating the performance of three commercial NAATs to detect NG and CT in the rectum and pharynx. A fourth NAAT will be used as a tiebreaker. The performance of the fourth NAAT will not be evaluated. Each manufacturer will provide a specific swab collection kit and transport media.

This research study will take place at healthcare clinics that focus on sexually transmitted infections, women's health, student health, family planning, and lesbian, gay, bisexual, and transgender (LGBT) health. This research will include specimens collected from adult males, females, and transgender persons seeking sexually transmitted infection (STI) testing at the participating study clinics. Both symptomatic and asymptomatic participants are included in the study population.

Potential participants will be identified, assessed for eligibility, and asked to provide oral informed consent. If a potential participant agrees to take part in the research, the participant will have eight total swabs collected: four swabs from the pharynx and four swabs from the rectum. The swabs needed for routine clinical care are taken first prior to collection of the research study swabs. All study procedures take place during one clinic visit; there are no follow-up visits as part of the study. Participants continue with routine clinical care as directed by their medical providers.

Subject participation is confidential and anonymous. The results of the tests and participation in this research are not placed in the participant's medical records.

Each study swab is used for a specific NAAT and tested at one of the two reference testing laboratories. The Anatomic Site Infection Status (ASIS) is defined by the results of the two other NAATs, and, if necessary, results from the tiebreaker NAAT. Each anatomic site is considered in isolation. If fewer than four swabs at an anatomic site are completed, then the test results from that specific anatomic site are excluded from analysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02870101
Study type Interventional
Source Duke University
Contact
Status Completed
Phase N/A
Start date April 10, 2017
Completion date March 12, 2018

See also
  Status Clinical Trial Phase
Completed NCT01144871 - Parental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for Teens N/A
Completed NCT04661566 - Optimizing a Multi-Modal Intervention to Reduce Health-Risking Sexual Behaviors: Component Selection N/A
Completed NCT01842100 - To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy N/A
Completed NCT04867798 - Transgender Men and HIV in Uganda: PrEP Uptake and Persistence
Active, not recruiting NCT04328025 - Peer-Delivered HIV Self-Testing, STI Self-Sampling and PrEP for Transgender Women in Uganda N/A
Completed NCT02509572 - Improvement of STI Detection in Adolescent Emergency Department Patients N/A
Active, not recruiting NCT04758390 - A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women N/A
Completed NCT03528135 - Project PRIDE (Promoting Resilience In Discriminatory Environments) N/A
Recruiting NCT04547413 - STI/HIV Intervention Behavioral Intervention Program N/A
Completed NCT01784809 - The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders Phase 2
Completed NCT01136850 - Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea Phase 3
Completed NCT02461940 - STI/HIV Prevention Intervention for Adolescents in Singapore N/A
Completed NCT00469547 - 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides Phase 1
Completed NCT01285349 - HIV/STI Prevention for Drug-Involved Couples N/A
Completed NCT02391233 - Multimedia WORTH With Black Drug-Involved Women on Probation N/A
Completed NCT02183909 - Connecting Resources for Urban Sexual Health N/A
Completed NCT02882607 - Peer Groups for Healthy Pregnancy & HIV Prevention for Young Malawian Women N/A
Completed NCT00362375 - Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women Phase 1/Phase 2
Active, not recruiting NCT04710784 - A Pragmatic Trial to Expand Youth-friendly HIV Self-testing N/A
Recruiting NCT06223165 - Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot N/A